Scientific Program > Confirmed Speakers
Benoit Arsenault
Laval University Canada [Session 6]
Hypertriglyceridemic Waist: A simple Tool
Philip Barter
University of New South Wales Australia [Session 1]
[Session 4]
HDL as a Therapeutic Target: A Critical Appraisal
André Carpentier
Sherbrooke University Canada [Session 2]
Partition of Dietary Fatty Acid Metabolism in Type 2 Diabetes
Juliana Chan
Chinese University of Hong Kong China (HK) [Session 1]
Type 2 Diabetes and Cardiometabolic Risk in Asia
Peter Clifton
University of South Australia Australia [Session 8]
Nutrition and CVD Prevention: What Should We Aim For?
Jean-Pierre Després
Laval University Canada [Session 7]
Targeting Cardiometabolic Risk in Clinical Practice: Is Weight Loss the Right Target?
Amalia Gastaldelli
 Institute of Clinical Physiology of CNR of Pisa Italy [Session 4]
Ectopic Fat: The True Culprit Linking Obesity and Cardiovascular Disease?
Frank Hu
Harvard Medical School USA [Session 9]
Healthy Drinking: An Important Component of a Healthy Lifestyle
Michael Jensen
Mayo Clinic USA [Session 1]
Jean Vague & Per Björntorp Award
Fredrik Karpe
University of Oxford UK [Session 3]
Molecular Aspects of Insulin Resistance in Abdominal Obesity
Hyo-Soo Kim
Seoul National University Hospital Korea [Session 4]
Cloning of New Receptor for Resistin: Mechanism of Inflammation at Adipose Tissue and Atherosclerosis
Jae Bum Kim
Seoul National University Korea [Session 5]
Lipid Dysregulation and Metabolic Complications
Yangha Kim
Ewha Womans University Korea [Session 5]
Thermogenic Agent in the Management of Cardiometabolic Risk
Kwang Kon Koh
Gachon University Gil Hospital Korea [Session 6]
To Target or not To Target LDL-Cholesterol? That is the Question
Benoît Lamarche
Laval University Canada [Session 8]
Reshaping Nutritional Habits in Clinical Practice
In Kyu Lee
Kyungpook National University Korea [Session 5]
Regulation of PDH (Pyruvate Dehydrogenase) Flux and Insulin Resistance in Vascular Calcification
Peter Libby
Brigham and Women's Hospital USA [Session 4]
Abdominal Obesity, Type 2 Diabetes and Cardiovascular Disease: Is Inflammation the Missing Link?
Soo Lim
Seoul National University Bundang Hospital Korea [Session 1]
Abdominal Obesity in Korea
André Marette
Laval University Canada [Session 3]
Inflammation, Adipose Tissue and Cardiometabolic Risk
Yuji Matsuzawa
Osaka University Japan [Session 1]
Abdominal Obesity: State of the Art
Kyong Soo Park
Seoul National University Hospital Korea [Session 5]
Nuclear Receptors and Fatty Acid Metabolism in Skeletal Muscle
Denis Richard
Laval University Canada [Session 6]
Global Cardiometabolic Approach Organization as a Model (CMDO)
Robert Ross
Queen's University Canada [Session 7]
Physical Activity/Exercise in the Management of Abdominal Obesity
Ulf Smith
University of Gothenburg Sweden [Session 3]
Abdominal Obesity, Adipocytes and Inflammation
Mitsuyoshi Takahara
Osaka University Graduate School of Medicine Japan [Session 3]
Obesity, Adiponectin and Cardiometabolic Risk: An Update
Marja-Riitta Taskinen
Helsinki University Finland [Session 2]
Ectopic Fat: An Important Feature of Visceral Obesity and Type 2 Diabetes
André Tchernof
Laval University Cananda [Session 2]
Visceral Adipose Tissue Metabolism in Human
Luc Van Gaal
Antwerp Univeristy Hospital Belgium [Session 6]
Targeting Abdominal Obesity in Diabetology: What Can We Do?
Samuel Virtue
University of Cambridge UK [Session 3]
Adipose Tissue and Cardiometabolic Risk: Mechanistic Insights